Clinical Trials Browser

Phase 2 × Amiodarone × 90 days × Clear all

NCT06067438 2026-05-22

Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer

Phase 2 Recruiting

Gastrointestinal

Atrial Fibrillation, Esophageal Neoplasms